4th Virtual International Digestive Disease Symposium (DDI)
3rd Virtual Diabetes, Obesity and Cardiovascular Disease Summit (DOCS)

17th – 20th September 2020

Welcome Message

Dear Colleagues,

As you know, the 4th Annual International Digestive Disease Symposium (DDI 2020) and 3rd Annual Diabetes, Obesity and Cardiovascular Disease Summit (DOCS 2020) was originally scheduled for March 19 – 21. However, given the ongoing COVID-19 pandemic, it is unlikely that an in-person event is feasible in the near future. Therefore, we have decided to reinvent DDI-DOCS as a virtual event and it will take place from September 17 – 20.

The feedback from last year attendees was very positive, and we expect that this set-up will allow us to maximize the educational material and reach a larger audience with a greater cross-section of topics.

The Virtual Conference will be held completely online and will comprise the same content that had been planned for the in-person event.

The DDI Symposium aims to provide its participants with the latest, evidence based and state-of-the-art lectures addressing a spectrum of common and complex topics. This scientific program is specifically developed to present up to date, data driven management of a variety of conditions including medical and surgical approaches to: liver and pancreatic diseases, inflammatory bowel disease, esophageal disorders, gastrointestinal oncology, colorectal disorders, metabolic and bariatric surgery, hernia repair, general gastroenterology, and nutritional conditions.

In addition, this year the content will be expanded to include new topics including breast surgery and robotic surgery, in line with feedback from participants and new services at Cleveland Clinic Abu Dhabi.

The DDI Symposium will consist of diverse lectures and break-out sessions with lively debates by leading local and international experts from Cleveland Clinic Abu Dhabi, Cleveland Clinic Ohio, and other international academic medical centres. We expect over 300 delegates, who will be provided with ample opportunities for interactive participation and discussion. The program is designed to showcase the latest in medical, surgical, minimally invasive, robotic, and endoscopic therapies.

The Diabetes, Obesity, and Cardiovascular Diseases Summit 2020 will be a multidisciplinary, comprehensive program that aims to provide participants with the newest data-driven therapies to treat obesity and metabolic diseases. The program is specifically developed to allow for the exchange of new data and treatment strategies available to address the broad-spectrum of metabolic diseases associated with obesity. DOCS 2020 will consist of diverse lectures and breakout sessions with lively debates by leading local and international experts from Cleveland Clinic Abu Dhabi, and other leading international academic medical centers. We expect over 200 participants comprised of physicians including internists, family practitioners, general practitioners, obesity medicine specialists, endocrinologists, cardiologists, general and bariatric surgeons, dietitians, nutritionists, psychiatrists, exercise physiologists and other providers involved in the multidisciplinary care of patients with obesity.

These events will be a platform for professional networking amongst faculty, delegates and exhibitors from the United Arab Emirates and abroad.

On behalf of the Cleveland Clinic Abu Dhabi, welcome and we wish you an enjoyable and productive time at the conference.

Matthew Kroh, MD
Institute Chair
Digestive Disease Institute
Cleveland Clinic Abu Dhabi

Sigurbjorn Birgisson, MD
Scientific Program Chair
Digestive Disease Institute
Cleveland Clinic Abu Dhabi

Ricard Corcelles, MD
Scientific Program Chair
Digestive Disease Institute
Cleveland Clinic Abu Dhabi